1. Home
  2. TSBX vs CNVS Comparison

TSBX vs CNVS Comparison

Compare TSBX & CNVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TSBX
  • CNVS
  • Stock Information
  • Founded
  • TSBX 2015
  • CNVS 2000
  • Country
  • TSBX United States
  • CNVS United States
  • Employees
  • TSBX N/A
  • CNVS N/A
  • Industry
  • TSBX
  • CNVS Consumer Electronics/Video Chains
  • Sector
  • TSBX
  • CNVS Consumer Discretionary
  • Exchange
  • TSBX Nasdaq
  • CNVS Nasdaq
  • Market Cap
  • TSBX 11.8M
  • CNVS 12.9M
  • IPO Year
  • TSBX 2023
  • CNVS 2003
  • Fundamental
  • Price
  • TSBX $0.48
  • CNVS $1.01
  • Analyst Decision
  • TSBX Strong Buy
  • CNVS Buy
  • Analyst Count
  • TSBX 2
  • CNVS 1
  • Target Price
  • TSBX $6.88
  • CNVS $9.00
  • AVG Volume (30 Days)
  • TSBX 134.2K
  • CNVS 91.4K
  • Earning Date
  • TSBX 11-07-2024
  • CNVS 11-12-2024
  • Dividend Yield
  • TSBX N/A
  • CNVS N/A
  • EPS Growth
  • TSBX N/A
  • CNVS N/A
  • EPS
  • TSBX N/A
  • CNVS N/A
  • Revenue
  • TSBX N/A
  • CNVS $45,278,000.00
  • Revenue This Year
  • TSBX N/A
  • CNVS $26.40
  • Revenue Next Year
  • TSBX N/A
  • CNVS N/A
  • P/E Ratio
  • TSBX N/A
  • CNVS N/A
  • Revenue Growth
  • TSBX N/A
  • CNVS N/A
  • 52 Week Low
  • TSBX $0.45
  • CNVS $0.72
  • 52 Week High
  • TSBX $5.75
  • CNVS $3.93
  • Technical
  • Relative Strength Index (RSI)
  • TSBX 22.35
  • CNVS 62.21
  • Support Level
  • TSBX $0.45
  • CNVS $0.95
  • Resistance Level
  • TSBX $0.70
  • CNVS $1.03
  • Average True Range (ATR)
  • TSBX 0.05
  • CNVS 0.08
  • MACD
  • TSBX 0.03
  • CNVS 0.01
  • Stochastic Oscillator
  • TSBX 11.83
  • CNVS 71.87

About TSBX Turnstone Biologics Corp.

Turnstone Biologics Corp is a clinical-stage biotechnology company focused on developing new medicines to treat and cure patients with solid tumors. The company is pioneering a differentiated approach to tumor-infiltrating lymphocytes, or TILs, a clinically validated technology for treating solid tumors. It is developing next-generation TIL therapies by selecting the most potent and tumor-reactive T cells, which are referred to as Selected TILs. TILs are a type of cell therapy that harnesses the patient's own immune cells to target their own tumors. TIL therapy involves the isolation of lymphocytes from the patient's tumor, expansion of the isolated cells outside the body, and then infusion of the cells back into the patient.

About CNVS Cineverse Corp.

Cineverse Corp is a main streaming technology and entertainment company. It operates portfolios of owned and operated streaming channels, all powered by its, proprietary technology platform. Cineverse features enthusiast brands for subscription video on demand (SVOD), advertising-based video on demand (AVOD), and free, ad-supported streaming television (FAST) channels. The company earns fees for the distribution of content in the home entertainment markets via several distribution channels, including digital, video-on-demand, and physical goods (e.g., DVDs and Blu-ray Discs) (Base Distribution).

Share on Social Networks: